Mobile Menu - OpenMobile Menu - Closed

Hearing on “Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain”

Date: 
Thursday, May 9, 2019 - 10:00am
Location: 
2322 Rayburn House Office Building
Subcommittees: 

The Subcommittee on Health of the Committee on Energy and Commerce held a hearing on Thursday, May 9, 2019, at 10 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled “Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain.”

 

Livestream

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Health

Opening Statement of Chairman Pallone as prepared for delivery 

Opening Statement of Subcommittee Chairwoman Eshoo as prepared for delivery 

 

Witnesses

Panel I

Justin McCarthy
Senior Vice President, Patient & Health Impact Group
Pfizer

Testimony

 

Kave Niksefat
Vice President, Value and Access
Amgen

Testimony

 

Jeffrey Hessekiel
Executive Vice President & General Counsel
Exelixis

Testimony

 

Amy Bricker
Senior Vice President, Supply Chain
Express Scripts

Testimony

 

Brent Eberle
Chief Pharmacy Officer
Navitus Health Solutions

Testimony

 

Panel II

Estay Greene
Vice President of Pharmacy Services
Blue Cross Blue Shield of North Carolina

Testimony

 

Lynn Eschenbacher
Chief Pharmacy Officer
Ascension

Testimony

 

Jack Resneck, M.D.
Chair, Board of Trustees
American Medical Association

Testimony

 

Richard Ashworth
President of Pharmacy
Walgreens

Testimony

 

Leigh Purvis
Director of Health Services Research
AARP

Testimony

 

Issues: